Karalee Watts
Physician Assistant · Glen Burnie, MDNPI 1972169191
Payments from drug & device makers
Across 61 payments — averaging $26.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$381
- AstraZeneca$164
- Bayer$161
- Novo Nordisk$161
- AbbVie$149
- Pfizer$127
- plus $495 from 16 others
What the payments were for
- Food & beverage$1,639100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 4 | $381 |
| AstraZeneca | 8 | $164 |
| Bayer | 6 | $161 |
| Novo Nordisk | 8 | $161 |
| AbbVie | 7 | $149 |
| Pfizer | 2 | $127 |
| Boehringer Ingelheim | 6 | $98 |
| Gilead | 3 | $73 |
| GSK | 3 | $53 |
| Lilly USA, LLC | 2 | $37 |
| Johnson & Johnson | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Globus Medical | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Merck | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,639 in reported general payments places this provider in the 80th percentile of 2,567 physician assistant providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $51,371 |
| EliquisApixaban | 21 | $30,562 |
| JardianceEmpagliflozin | 19 | $25,395 |
| LinzessLinaclotide | 25 | $13,365 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,944 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 91 | $2,584 |
| Atorvastatin Calcium | 207 | $1,684 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $1,666 |
| ValacyclovirValacyclovir Hcl | 30 | $1,051 |
| Gabapentin | 59 | $965 |
| Fluticasone Propionate | 53 | $834 |
| Pantoprazole Sodium | 85 | $783 |
| Lisinopril | 103 | $766 |
| Omeprazole | 54 | $675 |
| Pravastatin Sodium | 36 | $661 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $161 | $51,37143 claims |
| PfizerEliquis | $127 | $30,56221 claims |
| Boehringer IngelheimJardiance | $98 | $25,39519 claims |
| AbbVieLinzess | $149 | $13,36525 claims |
| GSKBreo Ellipta | $53 | $5,94412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Glen Burnie
- Rebekah ChenGlen Burnie$14K
- Manuel SkowGlen Burnie$13K
- Phnonia RojasGlen Burnie$10K
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.